Molecular Epidemiology of Mycobacterium tuberculosis To Describe the Transmission Dynamics Among Inuit Residing in Iqaluit Nunavut Using Whole-Genome Sequencing.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
15 06 2021
Historique:
received: 09 12 2019
accepted: 10 04 2020
pubmed: 16 4 2020
medline: 25 6 2021
entrez: 16 4 2020
Statut: ppublish

Résumé

In the last decade, tuberculosis (TB) incidence among Inuit in the Canadian Arctic has been rising. Our aim was to better understand the transmission dynamics of TB in this remote region of Canada using whole-genome sequencing. Isolates from patients who had culture-positive pulmonary TB in Iqaluit, Nunavut, between 2009 and 2015 underwent whole-genome sequencing (WGS). The number of transmission events between cases within clusters was calculated using a threshold of a ≤3 single nucleotide polymorphism (SNP) difference between isolates and then combined with detailed epidemiological data using a reproducible novel algorithm. Social network analysis of epidemiological data was used to support the WGS data analysis. During the study period, 140 Mycobacterium tuberculosis isolates from 135 cases were sequenced. Four clusters were identified, all from Euro-American lineage. One cluster represented 62% of all cases that were sequenced over the entire study period. In this cluster, 2 large chains of transmission were associated with 3 superspreading events in a homeless shelter. One of the superspreading events was linked to a nonsanctioned gambling house that resulted in further transmission. Shelter to nonshelter transmission was also confirmed. An algorithm developed for the determination of transmission events demonstrated very good reproducibility (κ score .98, 95% confidence interval, .97-1.0). Our study suggests that socioeconomic factors, namely residing in a homeless shelter and spending time in a gambling house, combined with the superspreading event effect may have been significant factors explaining the rise in cases in this predominantly Inuit Arctic community.

Sections du résumé

BACKGROUND
In the last decade, tuberculosis (TB) incidence among Inuit in the Canadian Arctic has been rising. Our aim was to better understand the transmission dynamics of TB in this remote region of Canada using whole-genome sequencing.
METHODS
Isolates from patients who had culture-positive pulmonary TB in Iqaluit, Nunavut, between 2009 and 2015 underwent whole-genome sequencing (WGS). The number of transmission events between cases within clusters was calculated using a threshold of a ≤3 single nucleotide polymorphism (SNP) difference between isolates and then combined with detailed epidemiological data using a reproducible novel algorithm. Social network analysis of epidemiological data was used to support the WGS data analysis.
RESULTS
During the study period, 140 Mycobacterium tuberculosis isolates from 135 cases were sequenced. Four clusters were identified, all from Euro-American lineage. One cluster represented 62% of all cases that were sequenced over the entire study period. In this cluster, 2 large chains of transmission were associated with 3 superspreading events in a homeless shelter. One of the superspreading events was linked to a nonsanctioned gambling house that resulted in further transmission. Shelter to nonshelter transmission was also confirmed. An algorithm developed for the determination of transmission events demonstrated very good reproducibility (κ score .98, 95% confidence interval, .97-1.0).
CONCLUSIONS
Our study suggests that socioeconomic factors, namely residing in a homeless shelter and spending time in a gambling house, combined with the superspreading event effect may have been significant factors explaining the rise in cases in this predominantly Inuit Arctic community.

Identifiants

pubmed: 32293676
pii: 5819740
doi: 10.1093/cid/ciaa420
pmc: PMC8204784
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2187-2195

Subventions

Organisme : CIHR
ID : 152448
Pays : Canada

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Références

Int J Epidemiol. 2002 Oct;31(5):940-5
pubmed: 12435764
Lancet Infect Dis. 2013 Feb;13(2):137-46
pubmed: 23158499
N Engl J Med. 2011 Feb 24;364(8):730-9
pubmed: 21345102
Int J Tuberc Lung Dis. 2018 Oct 1;22(10):1135-1144
pubmed: 30236180
Sci Rep. 2016 Sep 12;6:33180
pubmed: 27615360
Can Commun Dis Rep. 2018 Mar 01;44(3-4):75-81
pubmed: 31007614
Int J Tuberc Lung Dis. 2001 Mar;5(3):257-65
pubmed: 11326825
Lancet Infect Dis. 2014 Apr;14(4):341-52
pubmed: 24631223
Am J Respir Crit Care Med. 2013 Mar 1;187(5):543-51
pubmed: 23262515
Lancet Respir Med. 2018 Apr;6(4):244-246
pubmed: 29595504
PLoS One. 2017 Oct 5;12(10):e0185656
pubmed: 28982116
J Epidemiol Community Health. 2019 May;73(5):401-406
pubmed: 30728201
CMAJ Open. 2016 Sep 16;4(3):E496-E506
pubmed: 27730114
PLoS Med. 2016 Oct 4;13(10):e1002137
pubmed: 27701423
Nat Commun. 2014 Sep 01;5:4812
pubmed: 25176035
Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):13609-14
pubmed: 26483462
J Infect Dis. 2015 Jun 15;211(12):1905-14
pubmed: 25576599
Am J Respir Crit Care Med. 2003 Dec 1;168(11):1353-7
pubmed: 14500266
Ann Am Thorac Soc. 2015 Aug;12(8):1153-62
pubmed: 26099015
BMC Genomics. 2016 Nov 2;17(1):847
pubmed: 27806686
PLoS Med. 2013;10(2):e1001387
pubmed: 23424287
CMAJ. 2007 Jul 17;177(2):155-60
pubmed: 17638953
BMC Med. 2016 Mar 23;14:21
pubmed: 27005433
Am J Epidemiol. 2002 Mar 15;155(6):565-71
pubmed: 11882530

Auteurs

Gonzalo G Alvarez (GG)

School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.
McGill International Tuberculosis Centre, McGill University Health Centre, Montreal, Quebec, Canada.

Alice A Zwerling (AA)

School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
McGill International Tuberculosis Centre, McGill University Health Centre, Montreal, Quebec, Canada.

Carla Duncan (C)

Public Health Ontario Laboratory, Public Health Ontario, Toronto, Ontario, Canada.

Christopher Pease (C)

Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.

Deborah Van Dyk (D)

Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

Marcel A Behr (MA)

McGill International Tuberculosis Centre, McGill University Health Centre, Montreal, Quebec, Canada.
The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.

Robyn S Lee (RS)

McGill International Tuberculosis Centre, McGill University Health Centre, Montreal, Quebec, Canada.
The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.

Sunita Mulpuru (S)

School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.

Smita Pakhale (S)

School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.

D William Cameron (DW)

School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.

Shawn D Aaron (SD)

School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.

Michael Patterson (M)

Department of Health, Government of Nunavut, Iqaluit, Nunavut, Canada.

Jean Allen (J)

Nunavut Tunngavik Inc, Iqaluit, Nunavut, Canada.

Kathryn Sullivan (K)

School of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Anne Jolly (A)

School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.

Meenu K Sharma (MK)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Frances B Jamieson (FB)

Public Health Ontario Laboratory, Public Health Ontario, Toronto, Ontario, Canada.
Department of Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH